bone marrow-derived MMSCs
/ Institute of Cell Therapy
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2020
Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stromal Cells for Osteoarthritis
(clinicaltrials.gov)
- P1/2; N=45; Recruiting; Sponsor: Institute of Cell Therapy
Clinical • New P1/2 trial • Immunology • Osteoarthritis • Pain • Rheumatology
1 to 1
Of
1
Go to page
1